SPI Pharma Inc:企業の戦略的SWOT分析

【英語タイトル】SPI Pharma Inc - Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(GDPH25384SA)・商品コード:GDPH25384SA
・発行会社(調査会社):GlobalData
・発行日:2017年2月1日
・ページ数:23
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥14,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD250 ⇒換算¥28,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD375 ⇒換算¥42,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

SPI Pharma Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

SPI Pharma Inc (SPI Pharma) provides pharmaceutical ingredients and technologies for patient-friendly dosage forms. The company undertakes the manufacturing and marketing of various pharmaceutical products and technologies to solve challenging formulation problems. It offers a wide range of pharmaceuticals products which contain antacid actives, soluble excipients, taste-masking technology actives, vaccine adjuvants and drug delivery systems for oral dose applications. SPI Pharma offers products in various formulations such as chewables, lozenges, powders and other patient-friendly dosage forms such as swallow tablets, chewable tablets, fast dissolve tablets and soft gelatin capsules. The company also offers contract manufacturing services to other companies. It operates business through its manufacturing sites, research and development centers and sales offices located in the UK, Canada, China, France and India. The company is a wholly owned subsidiary of SPI Holdings Inc. SPI Pharma is headquartered in Wilmington, Delaware, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 – About the Company 5
SPI Pharma Inc – Key Facts 5
SPI Pharma Inc – Key Employees 6
SPI Pharma Inc – Major Products and Services 7
SPI Pharma Inc – History 10
SPI Pharma Inc – Company Statement 11
SPI Pharma Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
SPI Pharma Inc – Business Description 13
SPI Pharma Inc – Corporate Strategy 14
SPI Pharma Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
SPI Pharma Inc – Strengths 15
SPI Pharma Inc – Weaknesses 16
SPI Pharma Inc – Opportunities 17
SPI Pharma Inc – Threats 18
SPI Pharma Inc – Key Competitors 19
Section 3 – Company’s Lifesciences Financial Deals and Alliances 20
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 21
SPI Pharma Inc, Recent Deals Summary 22
Section 4 – Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
SPI Pharma Inc, Key Facts 5
SPI Pharma Inc, Key Employees 6
SPI Pharma Inc, Major Products and Services 7
SPI Pharma Inc, History 10
SPI Pharma Inc, Other Locations 12
SPI Pharma Inc, Subsidiaries 12
SPI Pharma Inc, Key Competitors 19
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 21
SPI Pharma Inc, Recent Deals Summary 22

List of Figures
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 21

★調査レポート[SPI Pharma Inc:企業の戦略的SWOT分析] (コード:GDPH25384SA)販売に関する免責事項を必ずご確認ください。
★調査レポート[SPI Pharma Inc:企業の戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆